Bioventus Stock Filter Stocks by Fundamentals
| BVS Stock | USD 12.29 0.02 0.16% |
Bioventus fundamentals help investors to digest information that contributes to Bioventus' financial success or failures. It also enables traders to predict the movement of Bioventus Stock. The fundamental analysis module provides a way to measure Bioventus' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioventus stock.
Bioventus | Shares Owned by Institutions |
Bioventus Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bioventus from analyzing Bioventus' financial statements. These drivers represent accounts that assess Bioventus' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bioventus' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 1.2B | 1.2B | 1.2B | 546.5M | 688.0M | 1.2B |
Bioventus ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bioventus' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bioventus' managers, analysts, and investors.Environmental | Governance | Social |
Bioventus Institutional Holders
Institutional Holdings refers to the ownership stake in Bioventus that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bioventus' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bioventus' value.| Shares | State Street Corp | 2024-06-30 | 487.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 390.2 K | Renaissance Technologies Corp | 2024-09-30 | 387.9 K | Oberweis Asset Management Inc | 2024-06-30 | 380.9 K | Segall Bryant & Hamill | 2024-09-30 | 377.8 K | Pura Vida Investments, Llc | 2024-09-30 | 352.6 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 332.3 K | Northern Trust Corp | 2024-09-30 | 322.4 K | D. E. Shaw & Co Lp | 2024-09-30 | 321.6 K | Essex Woodlands Health Ventures | 2024-09-30 | 13 M | Juniper Investment Co, Llc | 2024-09-30 | 6.9 M |
Bioventus Fundamentals
| Return On Equity | -0.25 | ||||
| Return On Asset | 0.0248 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 1.14 B | ||||
| Shares Outstanding | 65.37 M | ||||
| Shares Owned By Insiders | 11.47 % | ||||
| Shares Owned By Institutions | 69.76 % | ||||
| Number Of Shares Shorted | 1.34 M | ||||
| Price To Earning | 6.96 X | ||||
| Price To Book | 5.39 X | ||||
| Price To Sales | 1.45 X | ||||
| Revenue | 512.35 M | ||||
| Gross Profit | 302.71 M | ||||
| EBITDA | (23.07 M) | ||||
| Net Income | (96.74 M) | ||||
| Cash And Equivalents | 34.36 M | ||||
| Cash Per Share | 0.56 X | ||||
| Total Debt | 394.85 M | ||||
| Debt To Equity | 1.17 % | ||||
| Current Ratio | 0.94 X | ||||
| Book Value Per Share | 2.28 X | ||||
| Cash Flow From Operations | 15.34 M | ||||
| Short Ratio | 2.52 X | ||||
| Earnings Per Share | (0.61) X | ||||
| Price To Earnings To Growth | 2.14 X | ||||
| Target Price | 14.67 | ||||
| Number Of Employees | 1.03 K | ||||
| Beta | 0.88 | ||||
| Market Capitalization | 802.06 M | ||||
| Total Asset | 810.91 M | ||||
| Retained Earnings | (321.54 M) | ||||
| Working Capital | 92.5 M | ||||
| Net Asset | 810.91 M |
About Bioventus Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioventus's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioventus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioventus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioventus Stock Analysis
When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.